Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$44.03 USD
-0.08 (-0.18%)
Updated May 17, 2024 03:59 PM ET
After-Market: $44.04 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Brokerage Reports
Bristol Myers Squibb Company [BMY]
Reports for Purchase
Showing records 281 - 300 ( 439 total )
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Countdown to EASL Begins: Presentation Titles Released
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Immuno-Oncology Key Opinion Leader Conference Call Recap
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R